Mydlo MD / Godec Prostate Cancer

Science and Clinical Practice
2. Auflage 2015
ISBN: 978-0-12-800592-7
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, 672 Seiten

Prostate Cancer, Science and Clinical Practice, Second Edition, continues to be an important translational reference that bridges the gap between science and clinical medicine. It reviews the biological processes that can be implicated in the disease, reviews current treatments, highlights the pitfalls where relevant, and examines the scientific developments that might result in future treatments. Key chapters from the previous edition have been updated, and a plethora of new chapters describe new concepts of prostate cancer biology and newly developed therapeutics. Each chapter has been written by internationally recognized specialists on prostate cancer epidemiology, genetic susceptibility, cancer metastases, prostate physiology, proteomics, new therapeutics, and clinical trials. - Presents a comprehensive, translational source for all aspects of prostate cancer in one reference work - Provides a common language for cancer researchers, oncologists, and urologists to discuss prostate tumors and how prostate cancer metastases affects other major organ systems - Offers insights to research clinicians, giving them a key understanding the molecular basis of prostate cancer - Offers insights to cancer researchers into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays

Autoren/Hrsg.

Mydlo MD, Facs

Godec, Ciril J.

Leseproben

List of Contributors

Philip H. Abbosh MD, PhD,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA

Firas Abdollah MD,     Vattikuti Urology Institute & VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA

Mohan P. Achary PhD,     Department of Radiation Oncology and Radiology, Temple University School of Medicine, Philadelphia, PA, USA

Shaheen Alanee MD, MPH,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA

Peter C. Albertsen MD, MS,     Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA

Yousef Al-Shraideh MD,     Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

Gerald Andriole MD,     Division of Urological Surgery, Washington University in St. Louis, St. Louis, MO, USA

Janet E. Baack Kukreja MD,     Department of Urology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Richard K. Babayan MD,     Boston University School of Medicine, Boston, MA, USA

Brock R. Baker BS,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA

Christopher E. Bayne MD,     Department of Urology, The George Washington University, Washington, DC, USA

Marijo Bilusic MD, PhD,     Department of Medical Oncology, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA

Leonard P. Bokhorst MD,     Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands

David B. Cahn DO, MBS,     Department of Urology, Einstein Healthcare Network, Philadelphia, PA, USA

Daniel J. Canter MD,     Department of Urology, Fox Chase Cancer Center and Einstein Healthcare Network, Philadelphia, PA, USA

David Y.T. Chen MD, FACS,     Department of Surgical Oncology, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA

Ronald C. Chen MD, MPH,     Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA

Juan Chipollini MD,     Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA

Peter L. Choyke MD,     Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Matthew R. Cooperberg MD, MPH,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA

Anthony Costello MD, FRACS, FRCSI,     Departments of Urology and Surgery, Royal Melbourne Hospital and University of Melbourne, Melbourne; Epworth Prostate Centre, Epworth Healthcare, Melbourne, Australia

E. David Crawford MD,     University of Colorado Health Science Center, Aurora, CO, USA

Curtiland Deville MD,     Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Sibley Memorial Hospital, Washington, DC, USA

Essel Dulaimi MD,     Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA

Danuta Dynda MD,     Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA

John B. Eifler MD,     Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

Cesar E. Ercole MD,     Center for Urologic Oncology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA

Daniel D. Eun MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA

Wouter Everaerts MD, PhD,     Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne; Department of Urology, Royal Melbourne Hospital, Parkville; and Epworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australia

Izak Faiena MD,     Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

Michael A. Ferragamo MD, FACS,     Department of Urology, State University of New York, University Hospital, Stony Brook, NY, USA

Chandra K. Flack MD,     Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA

Tullika Garg MD, MPH,     Urology Department, Geisinger Health System, Danville, PA, USA

Awet Gherezghihir MD,     Department of Surgery (Urology), The Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

Ciril J. Godec MD, PhD,     Department of Urology, SUNY Downstate University School of Medicine, Brooklyn, NY; Long Island College Hospital, Long Island, NY, USA

Leonard G. Gomella MD,     Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

Richard E. Greenberg MD, FACS,     Division of Urologic Oncology, Fox Chase Cancer Center, and Temple University School of Medicine, Philadelphia, PA, USA

Baruch Mayer Grob MD,     Urology Section, Hunter Holmes McGuire VA Medical Center, and Division of Urology, Virginia Commonwealth University Health System, Richmond, VA, USA

Giorgio Guazzoni MD,     Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy

Thomas J. Guzzo MD, MPH,     Division of Urology, The Hospital of the University of Pennsylvania, Philadelphia, PA, USA

Ahmed Haddad MBChB, PhD,     Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Maahum Haider MD,     Department of Urology, University of Washington School of Medicine, Seattle, WA, USA

Andrew C. Harbin MD,     Department of Urology, Temple University Hospital, Philadelphia, PA, USA

Eric M. Horwitz MD,     Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Ahmed A. Hussein MD,     Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Department of Urology, Cairo University, Oula, Giza, Egypt

Timothy Ito MD,     Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Thomas W. Jarrett MD,     Department of Urology, The George Washington University, Washington, DC, USA

Lawrence C. Jenkins MD, MBA,     Sexual and Reproductive Medicine Program, Urology Service, Memorial...